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ECG ROUNDS
Clinical History:
A 45-year-old hypertensive woman presented with syncope, diarrhoea and palpitations in the Accident and
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Question 1: What was the diagnosis?
A. Ventricular fibrillation
B. Torsade de pointes (polymorphic ventricular tachycardia)
C. Supraventricular tachycardia
D. Monomorphic ventricular tachycardia
This ECG case was prepared by: Dr. S. H. Wan
Prof. C. P. Lau
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Answer: B. Torsade de pointes (polymorphic
ventricular tachycardia)
The ECG strip showed broad polymorphic QRS
complexes compatible with ventricular tachycardia with
the so called twisting of the axis appearance (torsade de
pointes). The ventricular rate was around 200 per
minute. This form of tachycardia usually tends to be
rapid and produces symptoms of hypotension and may
even degenerates into ventricular fibrillation. As the
patient developed hypotension soon after the onset of
this polymorphic ventricular tachycardia, external DC
cardioversion was given. After the cardioversion, the
obove ECG strip was obtained (Figure 2).
Question 2: What was the underlying rhythm?
A. Sinus bradycardia
B. Prolonged QT interval
C. Normal sinus rhythm
D. Idioventricular rhythm
Answer : B. Prolonged QT interval
The ECG strip showed sinus rhythm of 70 per
minute with a corrected QTc interval of 544 ms. There
were also T wave inversions over leads I, II, aVL, aVF
and lateral chest leads. As the patient had recurrent
torsade de pointes, a temporary pacemaker was inserted
and the ventricle was paced at a rate of 100 per minute.
The ECG strip after the temporary pacing (VVI) was
shown in Figure 3. Subsequent history taking reviewed
that the patient was on diuretic treatment for her
hypertension and blood investigation showed
hypokalaemia of 2.4mmol/l. Intravenous potassium
replacement was commenced and the serum potassium
level normalised after 2 days. The ECG showed gradual
normalisation of the QTc interval and the temporary
pacing was removed subsequently.
There are various causes of the acquired prolonged
QT syndrome including antiarrhythmic agents, tricyclic
antidepressants, electrolyte disturbances (see Table 1).1-2
Terfenadine, a commonly used antihistamine for upper
respiratory tract infection, has been described to cause
torsade de pointes in conjunction with antimicrobials
such as erythromycin and antifungal agents.3-4 The main
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Figure 3: ECG strip showing pacing artefacts followed by ventricular complexes of a VVI temporary entricular
pacemaker at a pacing rate of 100 per minute
LEAD II HR =101 A=0
SPEED=25 MM/SEC ART=145/88(104) mmHg SP02=99% NIBP=11:00 168/ 88(116)
Table 1: Causes of acquired prolonged QT
syndrome and torsade de pointes
ECG findings are the prolonged QTc interval associated
with pauses. Post-pause or post-ectopic T wave changes
or U wave accentuation and ventricular bigemeny may
also be seen.5 The underlying mechanism for the
occurrence of this polymorphic ventricular tachycardia
appears to be due to early afterdepolarization (a form of
triggered activity).
Treatment of this acquired long QT syndrome
(LQTS) includes prompt withdrawal of the offending
agent, replacement of electrolytes (e.g. potassium,
calcium or magnesium) and intravenous infusion of
isoprenaline or ventricular pacing to maintain a
ventricular rate of > 90 per minute. Interestingly,
intravenous magnesium has been shown to be effective
in suppressing drug induced torsade de pointes even in
patients with a normal magnesium level.6 |
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